Abstract

Sachin D. Patil*, Vishal A. More, Pranav R. Wable, Amit K. Patil, Kalpesh M. Patil

ABSTRACT

Vitiligo is a common skin disorder characterized by depigmentation due to the loss of melanocytes. This systematic review examines recent advances in vitiligo treatments, highlighting therapeutic options, their efficacy, and emerging trends in management. Skin cells (melanocytes) are responsible for producing melanin, the substance that gives pigmentation to the skin. This review aims to provide a comprehensive overview of the current state of knowledge about vitiligo. Although there is no specific ethnic group, gender, or skin type that is more prone to vitiligo than others, it can affect anyone. The most commonly prescribed treatments for vitiligo are systemic and topical phototherapy and Immunomodulators such as corticosteroids, calipering inhibitors, and vitamin D analogues.